Admetsys
For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Admetsys Information
Geographic Data
Address:
City: Boston
State: New York
Zip:
Country: United States
Financial Info
Stage:
grant
Raised Last:
$35k
Raised Total:$35k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose. The system has undergone 3 successful FDA-approved clinical trials with 97% control between 80–125 mg/dl and zero incidents of low blood sugar.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Grant | 1 | $35k |
Texas A&a;M New Ventures Competition Texas A&a;M New Ventures Competition |
3/2015 | Grant | 2 | - |
MedTech Innovator TMCx Accelerator MedTech Innovator TMCx Accelerator |
3/2016 | Seed Round | 2 | - |
Dreamit Healthtech Dreamit Ventures Dreamit Healthtech Dreamit Ventures |
1/2014 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
3/2016 | Seed Round | 2 | - |
Dreamit Healthtech Dreamit Ventures Dreamit Healthtech Dreamit Ventures |
3/2015 | Grant | 2 | - |
MedTech Innovator TMCx Accelerator MedTech Innovator TMCx Accelerator |
1/2014 | Non Equity Assistance | 1 | - |
MassChallenge MassChallenge |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
